Clinical Trial Update: Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tretinoin with or without fenretinide for patients with dysplastic nevus syndrome-related melanoma (skin cancer) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Fenretinide (fenretinide)
• TRETINOIN (TRETINOIN)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED